BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 26690594)

  • 41. Defective FAS-Mediated Apoptosis and Immune Dysregulation in Gaucher Disease.
    Miano M; Madeo A; Cappelli E; Lanza F; Lanza T; Stroppiano M; Terranova P; Venè R; Bleesing JJH; Di Rocco M
    J Allergy Clin Immunol Pract; 2020; 8(10):3535-3542. PubMed ID: 32702516
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Novel insights into FAS defects underlying autoimmune lymphoproliferative syndrome revealed by studies in consanguineous patients.
    Ben-Mustapha I; Agrebi N; Barbouche MR
    J Leukoc Biol; 2018 Mar; 103(3):501-508. PubMed ID: 29345341
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Single-Nucleotide Polymorphisms of FAS and FASL Genes and Risk of Idiopathic Aplastic Anemia.
    Rehman S; Saba N; Naz M; Ahmed P; Munir S; Sajjad S; Tabassum S; Naseem L
    Immunol Invest; 2018 Jul; 47(5):484-491. PubMed ID: 29611722
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Autoimmune lymphoproliferative syndrome: A disorder of immune dysregulation.
    Paskiewicz A; Niu J; Chang C
    Autoimmun Rev; 2023 Nov; 22(11):103442. PubMed ID: 37683818
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A survey of 90 patients with autoimmune lymphoproliferative syndrome related to TNFRSF6 mutation.
    Neven B; Magerus-Chatinet A; Florkin B; Gobert D; Lambotte O; De Somer L; Lanzarotti N; Stolzenberg MC; Bader-Meunier B; Aladjidi N; Chantrain C; Bertrand Y; Jeziorski E; Leverger G; Michel G; Suarez F; Oksenhendler E; Hermine O; Blanche S; Picard C; Fischer A; Rieux-Laucat F
    Blood; 2011 Nov; 118(18):4798-807. PubMed ID: 21885602
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Association of FAS-670A/G and FASL-844C/T polymorphisms with idiopathic azoospermia in Western Iran.
    Asgari R; Mansouri K; Bakhtiari M; Bidmeshkipour A; Yari K; Shaveisi-Zadeh F; Vaisi-Raygani A
    Eur J Obstet Gynecol Reprod Biol; 2017 Nov; 218():55-59. PubMed ID: 28942044
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Autoimmune lymphoproliferative syndrome (ALPS) in a patient with a new germline Fas gene mutation.
    Del-Rey MJ; Manzanares J; Bosque A; Aguiló JI; Gómez-Rial J; Roldan E; Serrano A; Anel A; Paz-Artal E; Allende LM
    Immunobiology; 2007; 212(2):73-83. PubMed ID: 17336828
    [TBL] [Abstract][Full Text] [Related]  

  • 48. FasL -844T/C and Fas -1377G/A: mutations of pulmonary adenocarcinoma in South China and their clinical significances.
    Zhao H; Chen W; Du P; Sun A; Zhuang C; Tong J; Wang L
    Tumour Biol; 2015 Jun; 36(6):4319-26. PubMed ID: 25596086
    [TBL] [Abstract][Full Text] [Related]  

  • 49. ALPS, FAS, and beyond: from inborn errors of immunity to acquired immunodeficiencies.
    Consonni F; Gambineri E; Favre C
    Ann Hematol; 2022 Mar; 101(3):469-484. PubMed ID: 35059842
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Differential regulation of miR-146a/FAS and miR-21/FASLG axes in autoimmune lymphoproliferative syndrome due to FAS mutation (ALPS-FAS).
    Marega LF; Teocchi MA; Dos Santos Vilela MM
    Clin Exp Immunol; 2016 Aug; 185(2):148-53. PubMed ID: 27060458
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Autoimmune lymphoproliferative syndrome with somatic Fas mutations.
    Holzelova E; Vonarbourg C; Stolzenberg MC; Arkwright PD; Selz F; Prieur AM; Blanche S; Bartunkova J; Vilmer E; Fischer A; Le Deist F; Rieux-Laucat F
    N Engl J Med; 2004 Sep; 351(14):1409-18. PubMed ID: 15459302
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Genetic polymorphisms in the apoptosis-associated genes FAS and FASL and breast cancer risk.
    Crew KD; Gammon MD; Terry MB; Zhang FF; Agrawal M; Eng SM; Sagiv SK; Teitelbaum SL; Neugut AI; Santella RM
    Carcinogenesis; 2007 Dec; 28(12):2548-51. PubMed ID: 17962219
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Abnormal biomarkers predict complex FAS or FADD defects missed by exome sequencing.
    Rensing-Ehl A; Lorenz MR; Führer M; Willenbacher W; Willenbacher E; Sopper S; Abinun M; Maccari ME; König C; Haegele P; Fuchs S; Castro C; Kury P; Pelle O; Klemann C; Heeg M; Thalhammer J; Wegehaupt O; Fischer M; Goldacker S; Schulte B; Biskup S; Chatelain P; Schuster V; Warnatz K; Grimbacher B; Meinhardt A; Holzinger D; Oommen PT; Hinze T; Hebart H; Seeger K; Lehmberg K; Leahy TR; Claviez A; Vieth S; Schilling FH; Fuchs I; Groß M; Rieux-Laucat F; Magerus A; Speckmann C; Schwarz K; Ehl S;
    J Allergy Clin Immunol; 2024 Jan; 153(1):297-308.e12. PubMed ID: 37979702
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Polymorphisms in the FAS and FASL genes and risk of lung cancer in a Korean population.
    Park SH; Choi JE; Kim EJ; Jang JS; Lee WK; Cha SI; Kim CH; Kam S; Kim DS; Park RW; Kim YC; Han SB; Jung TH; Park JY
    Lung Cancer; 2006 Dec; 54(3):303-8. PubMed ID: 17014925
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Updated Understanding of Autoimmune Lymphoproliferative Syndrome (ALPS).
    Li P; Huang P; Yang Y; Hao M; Peng H; Li F
    Clin Rev Allergy Immunol; 2016 Feb; 50(1):55-63. PubMed ID: 25663566
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The combined risks of reduced or increased function variants in cell death pathway genes differentially influence cervical cancer risk and herpes simplex virus type 2 infection among black Africans and the Mixed Ancestry population of South Africa.
    Chattopadhyay K; Williamson AL; Hazra A; Dandara C
    BMC Cancer; 2015 Oct; 15():680. PubMed ID: 26458812
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The broad spectrum of autoimmune lymphoproliferative disease: molecular bases, clinical features and long-term follow-up in 31 patients.
    Campagnoli MF; Garbarini L; Quarello P; Garelli E; Carando A; Baravalle V; Doria A; Biava A; Chiocchetti A; Rosolen A; Dufour C; Dianzani U; Ramenghi U
    Haematologica; 2006 Apr; 91(4):538-41. PubMed ID: 16537120
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Autoimmune lymphoproliferative syndrome type III, an indefinite disorder.
    van der Werff ten Bosch J; Otten J; Thielemans K
    Leuk Lymphoma; 2001 May; 41(5-6):501-11. PubMed ID: 11378568
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The clinical spectrum in a large kindred with autoimmune lymphoproliferative syndrome caused by a Fas mutation that impairs lymphocyte apoptosis.
    Infante AJ; Britton HA; DeNapoli T; Middelton LA; Lenardo MJ; Jackson CE; Wang J; Fleisher T; Straus SE; Puck JM
    J Pediatr; 1998 Nov; 133(5):629-33. PubMed ID: 9821419
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Molecular genetic studies in lymphocyte apoptosis and human autoimmunity.
    Martin DA; Combadiere B; Hornung F; Jiang D; McFarland H; Siegel R; Trageser C; Wang J; Zheng L; Lenardo MJ
    Novartis Found Symp; 1998; 215():73-82; discussion 82-91. PubMed ID: 9760572
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.